Differential responsiveness to belimumab (BmAb) in combination with standard of care therapy in RF plus , TNF alpha-inhibitor and methotrexate partial responder subgroups of subjects with moderate-severe rheumatoid arthritis Genovese, M., Filipowicz-Sosnowska, A., Merrill, J., Wasko, M., Dilorio, E., Stevenson, J., Lisse, J., Zhong, J., Hall, L., Bieber, F., Zilberstein, M., LBRA01 Study Grp WILEY-BLACKWELL. 2005: S738

View details for Web of Science ID 000232207803534